394 related articles for article (PubMed ID: 27814820)
101. Is mammography for breast cancer screening cost-effective in both Western and asian countries?: results of a systematic review.
Yoo KB; Kwon JA; Cho E; Kang MH; Nam JM; Choi KS; Kim EK; Choi YJ; Park EC
Asian Pac J Cancer Prev; 2013; 14(7):4141-9. PubMed ID: 23991967
[TBL] [Abstract][Full Text] [Related]
102. [Evaluating the usefulness of a breast screening program in Bogotá, Colombia].
González-Mariño MA
Rev Salud Publica (Bogota); 2012; 14(1):41-52. PubMed ID: 23250314
[TBL] [Abstract][Full Text] [Related]
103. Mammographic screening: measurement of the cost in a population based programme in Victoria, Australia.
Hurley SF; Livingston PM; Thane N; Quang L
J Epidemiol Community Health; 1994 Aug; 48(4):391-9. PubMed ID: 7964340
[TBL] [Abstract][Full Text] [Related]
104. Utility of diagnostic breast excision biopsies during two decades of screening mammography.
Luiten JD; Voogd AC; Tjan-Heijnen VCG; Wesseling J; Luiten EJT; Duijm LEM
Breast; 2019 Aug; 46():157-162. PubMed ID: 31195315
[TBL] [Abstract][Full Text] [Related]
105. Will early detection of breast cancer reduce the costs of treatment?
Salkeld G; Gerard K
Aust J Public Health; 1994 Dec; 18(4):388-93. PubMed ID: 7718652
[TBL] [Abstract][Full Text] [Related]
106. Use and Costs of Breast Cancer Screening for Women in Their 40s in a US Population With Private Insurance.
Kunst N; Long JB; Xu X; Busch SH; Kyanko KA; Richman IB; Gross CP
JAMA Intern Med; 2020 May; 180(5):799-801. PubMed ID: 32202606
[TBL] [Abstract][Full Text] [Related]
107. Outcomes of modern screening mammography.
Kerlikowske K; Barclay J
J Natl Cancer Inst Monogr; 1997; (22):105-11. PubMed ID: 9709285
[TBL] [Abstract][Full Text] [Related]
108. Risk of breast cancer two years after a benign biopsy depends on the mammographic feature prompting recall.
Vernet-Tomás M; Louro J; Román M; Saladié F; Posso M; Prieto M; Vázquez I; Baré M; Peñalva L; Vidal C; Bargalló X; Sánchez M; Ferrer J; A Espinàs J; Quintana MJ; Rodríguez-Arana A; Castells X;
Maturitas; 2021 Feb; 144():53-59. PubMed ID: 33358209
[TBL] [Abstract][Full Text] [Related]
109. Cost implications of routine mammography screening of women 50-69 years in the county of Funen, Denmark.
Bech M; Gyrd-Hansen D
Health Policy; 2000 Nov; 54(2):125-41. PubMed ID: 11094266
[TBL] [Abstract][Full Text] [Related]
110. Preoperative evaluation of abnormal mammographic findings to avoid unnecessary breast biopsies.
Morrow M; Schmidt R; Cregger B; Hassett C; Cox S
Arch Surg; 1994 Oct; 129(10):1091-6. PubMed ID: 7944941
[TBL] [Abstract][Full Text] [Related]
111. Estimating the Breast Cancer Burden in Germany and Implications for Risk-based Screening.
Quante AS; Hüsing A; Chang-Claude J; Kiechle M; Kaaks R; Pfeiffer RM
Cancer Prev Res (Phila); 2021 Jun; 14(6):627-634. PubMed ID: 34162683
[TBL] [Abstract][Full Text] [Related]
112. How do I screen patients for breast cancer?
Krontiras H; Bramlett R; Umphrey H
Curr Treat Options Oncol; 2013 Mar; 14(1):88-96. PubMed ID: 23315271
[TBL] [Abstract][Full Text] [Related]
113. Healthcare and Cancer Treatment Costs of Breast Screening Outcomes among Higher than Average Risk Women.
Mittmann N; Blackmore KM; Seung SJ; Diong C; Done SJ; Chiarelli AM
Curr Oncol; 2023 Sep; 30(9):8550-8562. PubMed ID: 37754535
[TBL] [Abstract][Full Text] [Related]
114. Breast Imaging in Women Previously Irradiated for Hodgkin Lymphoma.
Horst KC; Fero KE; Hancock SL; Advani RH; Ikeda DM; Daniel B; Rosenberg SA; Donaldson SS; Hoppe RT
Am J Clin Oncol; 2016 Apr; 39(2):114-9. PubMed ID: 24390271
[TBL] [Abstract][Full Text] [Related]
115. Cost of breast-related care in the year following false positive screening mammograms.
Chubak J; Boudreau DM; Fishman PA; Elmore JG
Med Care; 2010 Sep; 48(9):815-20. PubMed ID: 20706161
[TBL] [Abstract][Full Text] [Related]
116. The cost-effectiveness of nationwide breast carcinoma screening in Finland, 1987-1992.
Leivo T; Sintonen H; Tuominen R; Hakama M; Pukkala E; Heinonen OP
Cancer; 1999 Aug; 86(4):638-46. PubMed ID: 10440691
[TBL] [Abstract][Full Text] [Related]
117. Role and evaluation of mammography and other imaging methods for breast cancer detection, diagnosis, and staging.
Feig SA
Semin Nucl Med; 1999 Jan; 29(1):3-15. PubMed ID: 9990680
[TBL] [Abstract][Full Text] [Related]
118. [Analysis of Cost-effectiveness of screening for breast cancer with conventional mammography, digital and magnetic resonance imaging].
Peregrino AA; Vianna CM; de Almeida CE; Gonzáles GB; Machado SC; Costa e Silva FV; Rodrigues MP
Cien Saude Colet; 2012 Jan; 17(1):215-22. PubMed ID: 22218554
[TBL] [Abstract][Full Text] [Related]
119. A roller coaster of emotions and sense--coping with the perceived psychosocial consequences of a false-positive screening mammography.
Bolejko A; Zackrisson S; Hagell P; Wann-Hansson C
J Clin Nurs; 2014 Jul; 23(13-14):2053-62. PubMed ID: 24313329
[TBL] [Abstract][Full Text] [Related]
120. Evaluating the correlation between film mammography and MRI for screening women with increased breast cancer risk.
Lee JM; Halpern EF; Rafferty EA; Gazelle GS
Acad Radiol; 2009 Nov; 16(11):1323-8. PubMed ID: 19632865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
